NCT06178770
- Conditions
- Neovascular Age-related Macular Degeneration
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Neovascular Age-related Macular Degeneration
Explore clinical trials studying Neovascular Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.
148 public trials
13 recruiting studies
Neovascular Age-related Macular Degeneration trial results
Completed
Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments
NCT06124677
- Conditions
- Neovascular Age-related Macular Degeneration
- Locations
-
- Miklos Schneider Glostrup Municipality, Denmark
Completed
Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography
NCT03909425
- Conditions
- Neovascular Age-related Macular Degeneration
- Locations
-
- Moorfields Eye Hospital NHS Foundation Trust, 162 City Road London, United Kingdom
Completed
A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD
NCT04632056
- Conditions
- Neovascular Age-related Macular Degeneration
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
NCT05569148
- Conditions
- Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
- Locations
-
- Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
- Associated Retina Consultants Phoenix, Arizona, United States
- Retinal Consultants of Arizona Phoenix, Arizona, United States
Completed
A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
NCT04480463
- Conditions
- Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
- Locations
-
- SCD Research Site Campbell, California, United States
- SCD Research Site Clearwater, Florida, United States
- SCD Research Site Coral Springs, Florida, United States
- SCD Research Site Fort Myers, Florida, United States
NCT04626128
- Conditions
- Neovascular Age-related Macular Degeneration
- Locations
-
- Retinal Consultants of Arizona Phoenix, Arizona, United States
- California Retina Consultants Bakersfield, California, United States
- Northern California Retina Vitreous Associates Medical Group, LLC Mountain View, California, United States
- Retinal Consultants Medical Group Sacramento, California, United States
NCT06021366
- Conditions
- Neovascular Age-related Macular Degeneration
- Locations
-
- Novartis Porto Salvo, Portugal
NCT03748784
- Conditions
- Blindness, Eye Diseases, Eye Diseases, Hereditary, +12 more
- Locations
-
- Adverum Clinical Site Bakersfield, California, United States
- Adverum Clinical Site Beverly Hills, California, United States
- Adverum Clinical Site Golden, Colorado, United States
- Adverum Clinical Site Deerfield Beach, Florida, United States
Completed
Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial
NCT03066258
- Conditions
- Neovascular Age-related Macular Degeneration, Wet Age-related Macular Degeneration
- Locations
-
- Santa Barbara location Santa Barbara, California, United States
- Baltimore location Baltimore, Maryland, United States
- Boston location Boston, Massachusetts, United States
- Reno location Reno, Nevada, United States